logo
What to know about tariffs: Key deadlines and rules

What to know about tariffs: Key deadlines and rules

Axios4 days ago

A series of milestone events in coming days will determine the course of the trade war.
Why it matters: That in turn will decide the fate of not only the U.S. economy, but the world's.
This is what you need to know about the days ahead.
What are the major tariff deadlines?
What to watch: There are key legal and diplomatic deadlines in coming weeks.
June 4: The U.S. expects best and final offers from trade partners, reports say.
June 5: The plaintiffs in the case that led to tariffs being struck down by the Court of International Trade have to file their papers with a federal appellate court, explaining why they oppose a motion to stay the trade court's ruling.
June 9: The government has to file a reply to those papers, after which time the appellate court could rule on issuing a stay or not.
End of June: President Trump has flagged the end of this month as possible timing for new tariffs that would affect cell phone makers like Apple and Samsung.
July 8: For most nations, this is the end of the 90-day pause on the sweeping global reciprocal tariffs that Trump imposed in early April, and then froze a week later.
July 9: The end of that pause for the European Union.
July 14: The EU will impose retaliatory tariffs on U.S. goods "if negotiations are not satisfactory," the bloc's top official said.
August 12: The end of a 90-day pause on retaliatory tariffs against China.
August 31: The end of an extension on long-standing exclusions for certain products from China tariffs.
What tariffs are in place now?
Zoom out: For now, all of the tariffs Trump previously imposed are still in effect, including a 10% global baseline tariff and additional levies on certain countries and sectors.
The U.S. Court of Appeals for the Federal Circuit temporarily stayed the Court of International Trade's ruling throwing out the tariffs Trump imposed under the 1977 International Emergency Economic Powers Act, or IEEPA.
That ruling did not affect tariffs previously imposed on sectors like steel and aluminum, which were implemented under a different authority.
Can Trump impose tariffs in other ways?
Zoom in: If the trade court's ruling striking down the IEEPA tariffs ends up standing, the administration has a variety of other levers it can pull to impose tariffs, though some are more time-consuming than what Trump has done thus far.
Section 232 tariffs are sectoral levies imposed in the interests of national security; they require studies first to determine impacts.
Section 301 tariffs are designed to respond to the unfair practices of foreign governments that put burdens on U.S. commerce. These also require an assessment process.
Section 338 tariffs date to 1930s-era trade law and give the president wide latitude to impose levies on other countries, with fewer restrictions or preliminary requirements.
What they're saying: " We're very, very confident that Plan A is all we're ever going to need," National Economic Council director Kevin Hassett told ABC last weekend, referring to the IEEPA tariffs.
But failing that, he said administration officials have been working on alternatives since 2017.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Sanofi (SNY) Stock Down 5% Despite AERIFY-1 Success
Sanofi (SNY) Stock Down 5% Despite AERIFY-1 Success

Yahoo

time20 minutes ago

  • Yahoo

Sanofi (SNY) Stock Down 5% Despite AERIFY-1 Success

Sanofi (NASDAQ:SNY)'s shares fell 5% this week, even as the company announced positive results from its AERIFY-1 trial with Regeneron Pharmaceuticals, marking a significant advance in COPD treatment. This decline comes in contrast to a 2% rise in the broader market, suggesting that investors may be focusing on other company initiatives, such as SNY's recent partnership with Stagecoach Performing Arts to raise awareness about Type 1 diabetes. Despite the short-term drop, Sanofi (NASDAQ:SNY)'s long-term performance remains strong. Over the past five years, the company has delivered a total return of 19.59%, outpacing both the French Pharmaceuticals sector and the broader market, which saw declines of 4% and 4.5% respectively in the past year. Analysts remain optimistic about Sanofi (NASDAQ:SNY)'s future, with the current share price at €95.9 and a consensus target of €117.17, an 18.5% potential upside. The company's Projections for 2028 include revenues of €51.2 billion and earnings of €10.2 billion, supported by innovative drug development and efficient operations. While we acknowledge the potential of SNY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None.

Viatris (VTRS) Faces Securities Fraud Class Action Over FDA Inspection Fallout
Viatris (VTRS) Faces Securities Fraud Class Action Over FDA Inspection Fallout

Yahoo

time20 minutes ago

  • Yahoo

Viatris (VTRS) Faces Securities Fraud Class Action Over FDA Inspection Fallout

On May 31, 2025, Viatris Inc. (NASDAQ:VTRS) became the subject of a securities fraud class action lawsuit filed in the U.S. District Court for the Western District of Pennsylvania. The suit alleges that between August 8, 2024, and February 26, 2025, the company and certain executives made materially false or misleading statements regarding the operational status of its Indore, India manufacturing facility. Ralf Kleemann/ The complaint centers on Viatris' public assurances that its facilities were in "good operating condition" and committed to "the highest quality manufacturing standards." However, following a failed inspection, the U.S. Food and Drug Administration issued a Warning Letter and Import Alert in December 2024 that affected 11 products, including the cancer drug Lenalidomide. On February 27, 2025, Viatris (NASDAQ:VTRS) disclosed that the inspection issues would negatively impact 2025 revenue by roughly $500 million and earnings from operations by about $385 million. This revelation led to a 15% drop in Viatris' stock price, from $11.24 to $9.53 per share. Investors who purchased Viatris securities during the specified period have until June 3, 2025, to seek appointment as lead plaintiff in the lawsuit. While we acknowledge the potential of VTRS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Vance says Musk's attacks on Trump were a "huge mistake" but tries to downplay spat
Vance says Musk's attacks on Trump were a "huge mistake" but tries to downplay spat

CBS News

time25 minutes ago

  • CBS News

Vance says Musk's attacks on Trump were a "huge mistake" but tries to downplay spat

Vice President JD Vance said Elon Musk was making a "huge mistake" going after President Trump in a storm of bitter and inflammatory social media posts after a falling out between the two men. But the vice president, in an interview released Friday after the very public blow-up between the world's richest man and arguably the world's most powerful, also tried to downplay Musk's blistering attacks as an "emotional guy" who got frustrated. Musk attacked Mr. Trump in a torrent of social media posts, first criticizing the president's spending package and then targeting him with more direct attacks. Mr. Trump then portrayed Musk as disgruntled and "CRAZY" and threatened to cut the government contracts held by Musk's businesses. Trump ally Steve Bannon called for an investigation into Musk's immigration status and alleged drug use. During an interview with comedian Theo Von, Vance said he hopes that "eventually Elon comes back into the fold," but said it might not be "possible now because he's gone so nuclear." The interview was taped on Thursday as Musk's posts were unfurling on X, the social media network the billionaire owns. "Look, it happens to everybody," Vance said in the interview. "I've flown off the handle way worse than Elon Musk did in the last 24 hours." Tesla and SpaceX CEO Elon Musk, President Donald Trump and Vice President JD Vance attend a campaign event, Oct. 5, 2024, in Butler, Pa. Alex Brandon / AP The vice president told Von that as Musk for days was calling on social media for Congress to kill Mr. Trump's "Big Beautiful Bill," the president was "getting a little frustrated, feeling like some of the criticisms were unfair coming from Elon, but I think has been very restrained because the president doesn't think that he needs to be in a blood feud with Elon Musk." "I actually think if Elon chilled out a little bit, everything would be fine," he added. Vance's comments come as other Republicans in recent days have urged the two men to mend fences. Just weeks ago, Mr. Trump and Musk were close allies, spending significant time together while the billionaire served as a special advisor to the president and led the "Department of Government Efficiency," or DOGE. Vance called Musk an "incredible entrepreneur," and said that DOGE, which sought to cut government spending and laid off or pushed out thousands of workers, was "really good." Vance defends Trump against Epstein allegations Musk, who runs electric vehicle maker Tesla, internet company Starlink and rocket company SpaceX, also claimed without evidence that the government was concealing information about the president's association with infamous pedophile Jeffrey Epstein. During the interview, Von showed the vice president Musk's claim that the Trump administration hasn't released all the records related to sex abuser Epstein because Mr. Trump is mentioned in them. Vance responded to that, saying, "Absolutely not. Donald Trump didn't do anything wrong with Jeffrey Epstein." Mr. Trump's name has been found in court documents related to Epstein's case, but his appearance in the documents is not evidence of wrongdoing. CBS News has previously covered Mr. Trump's presence in those documents. In February, the Department of Justice gave a group of right-wing influencers binders labeled "The Epstein Files: Phase 1," but the influencers later said that there was little new information in the files. Attorney General Pam Bondi later shared the documents widely and said the first phase "largely contains documents that have been previously leaked but never released in a formal capacity by the U.S. Government." She said more documents would be forthcoming, but there have been no other releases since. Musk appeared by Saturday morning to have deleted his posts about Epstein. "The president is doing a good job" Musk also shared a post calling for Mr. Trump to be impeached and replaced with Vance. He also called for the formation of a new political party. The vice president said comments like those were "just not helpful." "It's totally insane. The president is doing a good job," Vance told Von. The vice president also defended the bill that has drawn Musk's ire, and said its central goal was not to cut spending but to extend the 2017 tax cuts approved in Trump's first term. The bill would slash spending but also leave some 10.9 million more people without health insurance and spike deficits by $2.4 trillion over the decade, according to the nonpartisan Congressional Budget Office. Musk has warned that the bill will increase the federal deficit and called it a "disgusting abomination." Elon Musk and Vice President JD Vance listen as President Donald Trump speaks at a campaign rally, Oct. 5, 2024, in Butler, Pa. Evan Vucci / AP "It's a good bill," Vance said. "It's not a perfect bill." Vance also said it was ridiculous for some House Republicans who voted for the bill but later found parts objectionable to claim they hadn't had time to read it. The vice president said the text of the bill had been available for weeks. "The idea that people haven't had an opportunity to actually read it is ridiculous," Vance said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store